Thymic stromal lymphopoietin, but not ezrin, could be an early biomarker of airway epithelial dysfunction in acute allergic asthma

V. Kalinauskaite-Zukauske (Kaunas, Lithuania), A. Januskevicius (Kaunas, Lithuania), I. Janulaityte (Kaunas, Lithuania), K. Malakauskas (Kaunas, Lithuania)

Source: International Congress 2019 – Evaluation of basic science in airway diseases
Session: Evaluation of basic science in airway diseases
Session type: Poster Discussion
Number: 1702
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Kalinauskaite-Zukauske (Kaunas, Lithuania), A. Januskevicius (Kaunas, Lithuania), I. Janulaityte (Kaunas, Lithuania), K. Malakauskas (Kaunas, Lithuania). Thymic stromal lymphopoietin, but not ezrin, could be an early biomarker of airway epithelial dysfunction in acute allergic asthma. 1702

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Thymic stromal lymphopoietin (TSLP) as a local biomarker of hypertrophic changes in the synonasal mucosa in children with atopic bronchial asthma (BA) and allergic rhinitis (AR)
Source: Virtual Congress 2021 – New insight into the immunology of allergies, asthma and COPD: from mouse to man
Year: 2021


Steroid resistance of airway type 2 innate lymphoid cells from patients with severe asthma: the role of thymic stromal lymphopoietin
Source: International Congress 2018 – Roles of innate lymphoid cells in asthma
Year: 2018


Serum thymic stromal lymphopoietin level depends on allergic profile in pediatric asthma
Source: Virtual Congress 2021 – Paediatric lung disease: novel mechanisms, methods and translational studies
Year: 2021



Current evidence of epidermal barrier dysfunction and thymic stromal lymphopoietin in the atopic march
Source: Eur Respir Rev 2014; 23: 292-298
Year: 2014



Suppression of allergic airway inflammation in a mouse model of asthma by exogenous mesenchymal stem cells
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010

IL-4Ra signaling is required for thymic stromal lymphopoietin (TSLP)-induced type 2 airway inflammation
Source: Virtual Congress 2021 – Pearls in immunology, outcome studies and clinical trials in asthma, alpha-1 antitrypsin deficiency and COPD
Year: 2021



Thymic stromal lymphopoietin (TSLP) in naturally occurring asthma exacerbations in adults
Source: International Congress 2016 – New findings in mucosal immunology
Year: 2016

IL-25 secreted from epithelial cells has the potential to promote airway remodeling in asthma
Source: Annual Congress 2012 - Asthma and COPD: understanding through mechanisms
Year: 2012

Thymic stromal lymphopoietin promotes asthmatic airway remodeling in human lung fibroblast cells through stat3 signaling pathway
Source: Annual Congress 2012 - Mechanisms and modulation of allergic inflammation in the lung
Year: 2012

Interleukin-17A induces glucocorticoid insensitivity in human bronchial epithelial cells
Source: Eur Respir J 2012; 39: 439-445
Year: 2012



Mesenchymal stem cells down-regulate inflammation but not airway hyperresponsiveness in experimental asthma
Source: Annual Congress 2011 - Asthma: basic science and clinical studies
Year: 2011


Stem cell therapy attenuates airway and lung parenchyma remodeling in a murine model of chronic allergic asthma
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma
Year: 2008


IL-8 and TSLP production as markers of bronchial epithelial cell activation in IL-17A mediated airway inflammation in COPD: Role of tiotropium
Source: Annual Congress 2013 –New insights into epigenetic mechanisms in the lung
Year: 2013

Interaction between epithelial cells and sub-epithelial mesenchymal cells in severe non-allergic asthma
Source: International Congress 2019 – Pathophysiology and clinical insights into severe non-allergic asthma
Year: 2019


Blockade of thymic stromal lymphopoietin receptor (TSLPR) reduces atopic inflammation in a cynomolgus monkey model of asthma
Source: Annual Congress 2012 - Mechanisms and modulation of allergic inflammation in the lung
Year: 2012

Increased arginase activity contributes to airway remodelling in chronic allergic asthma
Source: Eur Respir J 2011; 38: 318-328
Year: 2011



Airway epithelial inflammatory responses and clinical parameters in COPD
Source: Eur Respir J 2003; 22: 94-99
Year: 2003



Galectn-3 : marker of airway inflammation in bronchial asthma
Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD
Year: 2018


Mast cells in COPD airways: relationship to bronchodilator responsiveness and angiogenesis
Source: Eur Respir J 2012; 39: 1361-1367
Year: 2012